ACAA2 p.Lys312Thr
c.935A>C · VCV3455278
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1222 | likely benign |
|---|---|---|
| REVEL | 0.365 | indeterminate |
| SaProt | LLR -10.39 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.4 | phastCons 1 |
| Regional constraint | o/e 0.97 | unconstrained · MANE · 30 kb · p 0.51 · regional, not allelic |
| Overall | ||
| CADD | 19.74 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0325% | 3,075 |
| Remaining individualsnot grpmax-eligible | 0.00178% | 56,300 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ACAA2
- Protein
- p.Lys312Thr
- Coding
- c.935A>C
- MANE Select
- NM_006111
- Type
- single nucleotide variant
- Location
- chr18:49787310 (GRCh38)
- Gene constraint
- LOEUF 1.148 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 97.49 · 2 PDB
- Residue 312
- a modified residue (n6-acetyllysine; alternate); a modified residue (n6-succinyllysine; alternate); an α-helix
Similar variants
- ACAA2 p.Lys312Asn Uncertain significance ★ ⚠ same residue
- ACAA2 p.Tyr198Asn Benign ★★ same type
- ACAA2 p.Ala183Thr Uncertain significance ★ ⚠ same type
- ACAA2 p.Ala196Thr Uncertain significance ★ ⚠ same type
- ACAA2 p.Ala250Thr Uncertain significance ★ ⚠ same type
- ACAA2 p.Ala267Gly Uncertain significance ★ ⚠ same type
- ACAA2 p.Ala70Ser Uncertain significance ★ ⚠ same type
- ACAA2 p.Arg133His Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/acaa2-p-lys312thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown